188 related articles for article (PubMed ID: 24010934)
1. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
Jiang YR; Yang YY; Chen YL; Liang ZJ
Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
[TBL] [Abstract][Full Text] [Related]
2. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
[TBL] [Abstract][Full Text] [Related]
3. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
Zhang S; Hou B; Yang H; Zuo Z
Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
[TBL] [Abstract][Full Text] [Related]
4. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
Chaudhaery SS; Roy KK; Saxena AK
J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865
[TBL] [Abstract][Full Text] [Related]
5. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
[TBL] [Abstract][Full Text] [Related]
6. Comparative QSAR studies using HQSAR, CoMFA, and CoMSIA methods on cyclic sulfone hydroxyethylamines as BACE1 inhibitors.
Zhang S; Lin Z; Pu Y; Zhang Y; Zhang L; Zuo Z
Comput Biol Chem; 2017 Apr; 67():38-47. PubMed ID: 28043074
[TBL] [Abstract][Full Text] [Related]
7. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
Sainy J; Sharma R
SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
[TBL] [Abstract][Full Text] [Related]
8. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
Roy KK; Dixit A; Saxena AK
J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163
[TBL] [Abstract][Full Text] [Related]
9. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
Shen LL; Liu GX; Tang Y
Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622
[TBL] [Abstract][Full Text] [Related]
11. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
[TBL] [Abstract][Full Text] [Related]
12. QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.
Sridhar J; Foroozesh M; Stevens CL
SAR QSAR Environ Res; 2011 Oct; 22(7-8):681-97. PubMed ID: 22004550
[TBL] [Abstract][Full Text] [Related]
13. Modeling study of phenylsulfonylfuroxan derivatives as P-gp inhibitors: a combined approach of CoMFA, CoMSIA and HQSAR.
Gadhe CG; Balupuri A; Balasubramanian PK; Cho SJ
Anticancer Agents Med Chem; 2014; 14(7):1019-30. PubMed ID: 24066798
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore based 3DQSAR of phenothiazines as specific human butyrylcholinesterase inhibitors for treatment of Alzheimer's disease.
Kundaikar HS; Agre NP; Degani MS
Curr Comput Aided Drug Des; 2014; 10(4):335-48. PubMed ID: 25794302
[TBL] [Abstract][Full Text] [Related]
15. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
Akula N; Lecanu L; Greeson J; Papadopoulos V
Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR studies on natural acetylcholinesterase inhibitors of Sarcococca saligna by comparative molecular field analysis (CoMFA).
Zaheer-ul-Haq ; Wellenzohn B; Tonmunphean S; Khalid A; Choudhary MI; Rode BM
Bioorg Med Chem Lett; 2003 Dec; 13(24):4375-80. PubMed ID: 14643329
[TBL] [Abstract][Full Text] [Related]
17. Receptor-based modeling and 3D-QSAR for a quantitative production of the butyrylcholinesterase inhibitors based on genetic algorithm.
Zaheer-ul H; Uddin R; Yuan H; Petukhov PA; Choudhary MI; Madura JD
J Chem Inf Model; 2008 May; 48(5):1092-103. PubMed ID: 18444627
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
Mondal C; Halder AK; Adhikari N; Jha T
Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
[TBL] [Abstract][Full Text] [Related]
19. Comparative QSAR studies on peptide deformylase inhibitors.
Lee JY; Doddareddy MR; Cho YS; Choo H; Koh HY; Kang JH; No KT; Pae AN
J Mol Model; 2007 May; 13(5):543-58. PubMed ID: 17333308
[TBL] [Abstract][Full Text] [Related]
20. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
Dowlati Beirami A; Hajimahdi Z; Zarghi A
J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
